These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9239771)
21. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716 [TBL] [Abstract][Full Text] [Related]
22. Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines. Tejedor JC; Brzostek J; Konior R; Grunert D; Kolhe D; Baine Y; Van Der Wielen M Clin Vaccine Immunol; 2016 Jul; 23(7):555-63. PubMed ID: 27145999 [TBL] [Abstract][Full Text] [Related]
23. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649 [TBL] [Abstract][Full Text] [Related]
24. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172 [TBL] [Abstract][Full Text] [Related]
25. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study. Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785 [TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA; Meschievitz CK; Ballanco GA; Daum RS Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752 [TBL] [Abstract][Full Text] [Related]
27. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults. Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Tejedor JC; Moro M; Merino JM; Gómez-Campderá JA; García-del-Rio M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Ruiz-Contreras J; Martin-Ancel A; Roca J; Boceta R; García-Corbeira P; Maechler G; Boutriau D; Pediatr Infect Dis J; 2008 Jul; 27(7):579-88. PubMed ID: 18536619 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains. Richmond P; Borrow R; Findlow J; Martin S; Thornton C; Cartwright K; Miller E Infect Immun; 2001 Apr; 69(4):2378-82. PubMed ID: 11254596 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
31. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Claesson BA; Schneerson R; Lagergård T; Trollfors B; Taranger J; Johansson J; Bryla D; Robbins JB Pediatr Infect Dis J; 1991 Aug; 10(8):560-4. PubMed ID: 1891286 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study. Carmona Martinez A; Prymula R; Miranda Valdivieso M; Otero Reigada MDC; Merino Arribas JM; Brzostek J; Szenborn L; Ruzkova R; Horn MR; Jackowska T; Centeno-Malfaz F; Traskine M; Dobbelaere K; Borys D Vaccine; 2019 Jan; 37(1):176-186. PubMed ID: 30054160 [TBL] [Abstract][Full Text] [Related]
33. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants. Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217 [TBL] [Abstract][Full Text] [Related]
35. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Ahman H; Käyhty H; Vuorela A; Leroy O; Eskola J Vaccine; 1999 Jun; 17(20-21):2726-32. PubMed ID: 10418924 [TBL] [Abstract][Full Text] [Related]
36. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000 [TBL] [Abstract][Full Text] [Related]
37. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286 [TBL] [Abstract][Full Text] [Related]
38. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586 [TBL] [Abstract][Full Text] [Related]
39. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435 [TBL] [Abstract][Full Text] [Related]
40. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Marques MB; Kasper DL; Shroff A; Michon F; Jennings HJ; Wessels MR Infect Immun; 1994 May; 62(5):1593-9. PubMed ID: 8168919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]